Laboratorio Clinico Jelmap

CLIA Laboratory Citation Details

2
Total Citations
11
Total Deficiencyies
7
Unique D-Tags
CMS Certification Number 40D0658214
Address Degetau 33, Juana Diaz, PR, 00795
City Juana Diaz
State PR
Zip Code00795

Citation History (2 surveys)

Survey - November 3, 2021

Survey Type: Standard

Survey Event ID: Q99D11

Deficiency Tags: D6144 D5437 D6144 D6093

Summary:

Summary Statement of Deficiencies D5437 CALIBRATION AND CALIBRATION VERIFICATION CFR(s): 493.1255(a) Unless otherwise specified in this subpart, for each applicable test system the laboratory must perform and document calibration procedures-- (1) Following the manufacturer's test system instructions, using calibration materials provided or specified, and with at least the frequency recommended by the manufacturer; (2) Using the criteria verified or established by the laboratory as specified in 493.1253(b) (3)-- (2)(i) Using calibration materials appropriate for the test system and, if possible, traceable to a reference method or reference material of known value; and (2)(ii) Including the number, type, and concentration of calibration materials, as well as acceptable limits for and the frequency of calibration; and (3) Whenever calibration verification fails to meet the laboratory's acceptable limits for calibration verification. This STANDARD is not met as evidenced by: Based on hematology calibration records reviewed (years 2019-2021) and laboratory director interview on November 2, 2021 at 10:30 AM, it was determined that the laboratory failed to perform the calibration verification procedures with at least the frequency recommended by the manufacturer's (each six months) for the hematology tests performed by the Coulter Act 2 diff hematology system. The findings include: 1. The laboratory uses a Coulter Act 2 diff hematology system for CBC (Complete blood count) patient's tests. 2. The manufacturer's instructions establishes that the laboratory must perform the calibration verification procedures each six months. 3. From May 5, 2019 to November 3, 2021, the records showed that the laboratory did not perform at least every 6 months the calibration verification procedures for the Coulter Act 2 diff hematology system. The calibration verification procedures were done on May 3, 2019, December 2, 2019 and February 2, 2020. 4. The laboratory processed and reported Three thousand eight hundred fifty three (3,853) Complete blood count (CBC) patient's samples from February 3, 2020 to November 2, 2021. (1,859 year 2020 and 1,994 year 2021) 5. The laboratory director confirmed on November 2, 2021 Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 2 -- that the laboratory did not perform at least every 6 months the calibration verification procedures for the Coulter Act 2 diff hematology system. D6093 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(e)(5) The laboratory director must ensure that the quality control programs are established and maintained to assure the quality of laboratory services provided and to identify failures in quality as they occur. This STANDARD is not met as evidenced by: Based on hematology calibration records reviewed (years 2019-2021) and laboratory director interview on November 2, 2021 at 10:30 AM, it was found that the laboratory director did not assure that quality control procedures related to calibration verification procedures werre followed. The findings include: 1. The laboratory did not perform, each six months, calibration verification procedures for hematology. Refer to D5437. D6144 GENERAL SUPERVISOR RESPONSIBILITIES CFR(s): 493.1463 The general supervisor is responsible for day-to-day supervision or oversight of the laboratory operation and personnel performing testing and reporting test results. This STANDARD is not met as evidenced by: Based on hematology calibration records reviewed (years 2019-2021) and laboratory director interview on November 2, 2021 at 10:30 AM, it was determined that the general supervisor did not assure that quality control procedures related to calibration and calibration verification procedures were followed. Refer to D5437. -- 2 of 2 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access

Survey - March 14, 2019

Survey Type: Complaint

Survey Event ID: U0MF11

Deficiency Tags: D3009 D6079 D6076 D3009 D6079 D3000 D6076

Summary:

Summary Statement of Deficiencies D3000 FACILITY ADMINISTRATION CFR(s): 493.1100 Each laboratory that performs nonwaived testing must meet the applicable requirements under 493.1101 through 493.1105, unless HHS approves a procedure that provides equivalent quality testing as specified in Appendix C of the State Operations Manual (CMS Pub. 7). (a) Reporting of SARS-CoV-2 test results During the Public Health Emergency, as defined in 400.200 of this chapter, each laboratory that performs a test that is intended to detect SARS-CoV-2 or to diagnose a possible case of COVID-19 (hereinafter referred to as a "SARS-CoV-2 test") must report SARS-CoV-2 test results to the Secretary in such form and manner, and at such timing and frequency, as the Secretary may prescribe. This CONDITION is not met as evidenced by: Based on review of records, observation and interview with the laboratory director on March 14, 2019, it was found that Laboratorio Clnico Jelmap processed and reported patient's samples without a valid (terminated) CLIA certificate. The finding include: 1. The laboratory processed and reported patient's samples from November 2017 to March 14, 2019, however the certificate expired on November 6, 2017. Refer to D 3009 D3009 FACILITIES CFR(s): 493.1101(c) The laboratory must be in compliance with applicable Federal, State, and local laboratory requirements. This STANDARD is not met as evidenced by: Based on observation, patient's accession lists, Puerto Rico Proficiency Program Statement of Deficiencies (X1) Provider/Supplier/CLIA Identification Number (X3) Date Survey Completed Name of Provider or Supplier Street Address, City, State -- 1 of 3 -- records, CLIA report 0850D, Puerto Rico state laboratories record review, laboratory workload and interview with the laboratory director on March 14, 2019, it was determined that the laboratory collected, processed and reported laboratory tests without a valid (terminated) CLIA certificate. The findings include: 1. On March 11, 2019 the CLIA report 0850D was reviewed to verify the laboratories expiration dates. When the the state record was compared with the CLIA 0850D, it was noticed that Laboratorio Clnico Jelmap, 40D0658214, was not included in the certificates expiring within 12 months. 2. The Puerto Rico Program test scores records were reviewed finding that the laboratory participated during year 2018. 3. An onsite visit to the laboratory was carried out in March 14, 2019 at 8:15 am. it was observed that the laboratory was opened to the public. 4. During interview with the laboratory director at the facility site he stated the following: a. After hurricane Mara the patient's samples were collected and referred to the reference laboratories. b. The laboratory began again to carry out laboratory tests in November 2017. c. That he did not pay the CLIA Certificate due to economic situation with the laboratory. 5. The accession lists of patient's, to whom laboratory services were offered, showed a total of 6,887 patient's from January 2018 to March 14, 2219. 6. The laboratory work load from November 2017 to March 13, 2019, showed that the laboratory processed and reported 63,868 analytes and tests. 7. The laboratory director was informed to stop patient testing. D6076 LABORATORY DIRECTOR CFR(s): 493.1441 The laboratory must have a director who meets the qualification requirements of 493. 1443 of this subpart and provides overall management and direction in accordance with 493.1445 of this subpart. This CONDITION is not met as evidenced by: Based on observations, patient's accession lists, workloads records and interview with the laboratory director on March 14, 2019, it was determined that the laboratory director director did not fulfill his responsibilities with the facility administration. Refer to 6079- The laboratory director did not ensure that the laboratory had a valid CLIA certificate to process patient's samples. D6079 LABORATORY DIRECTOR RESPONSIBILITIES CFR(s): 493.1445(a)(b) The laboratory director is responsible for the overall operation and administration of the laboratory, including the employment of personnel who are competent to perform test procedures, record and report test results promptly, accurately and proficiently, and for assuring compliance with the applicable regulations. (a) The laboratory director, if qualified, may perform the duties of the technical supervisor, clinical consultant, general supervisor, and testing personnel, or delegate these responsibilities to personnel meeting the qualifications under 493.1447, 493.1453, 493.1459, and 493.1487 respectively. (b) If the laboratory director reapportions performance of his or her responsibilities, he or she remains responsible for ensuring that all duties are properly performed. This STANDARD is not met as evidenced by: Based on observation and interview with the laboratory director on March 14, 2019 at -- 2 of 3 -- 8:15 a.m., it was determined that the laboratory director failed to be in compliance with the facility administration. The finding include: 1. The laboratory director did not ensure that the laboratory had a valid CLIA certificate to process patient's samples. 2. The Laboratory Clnico Jelmap collected, processed and reported patient's test samples in a facility without a valid (terminated) CLIA certificate since November 6, 2017. Refer to D 3000. -- 3 of 3 --

πŸ”’ Unlock Deficiency Summary

Get full access to the detailed deficiency summary for this facility

One-time payment β€’ Lifetime access